WGU D027 Advanced Pathopharmacological
Foundations Pre-Assessment Complete Question
Bank 2026-2027: 450 Questions with Detailed
Answers & Rationales Guaranteed Pass Study
Guide
WGU D027 Advanced Pathopharmacological Foundations — Practice Question Bank
Questions with Answers & Rationales
These are original exam-style practice questions, not copied WGU assessment items.
1.
A patient taking an ACE inhibitor develops a persistent dry cough. Which mechanism best
explains this adverse effect?
A. Increased aldosterone secretion
B. Accumulation of bradykinin
C. Increased angiotensin II production
D. Increased sodium retention
Correct Answer: B. Accumulation of bradykinin
Rationale: ACE normally breaks down bradykinin. ACE inhibition causes bradykinin
accumulation, which can produce a persistent dry cough.
2.
Which pharmacokinetic process describes movement of a drug from the bloodstream into body
tissues?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: B. Distribution
,Rationale: Distribution is the movement of a drug from systemic circulation into tissues and
body fluids. Absorption is entry into the bloodstream, metabolism is chemical modification, and
excretion is removal.
3.
A drug has a half-life of 8 hours. Approximately how long would it take to reach near steady-
state concentrations with repeated dosing?
A. 8 hours
B. 16 hours
C. 32–40 hours
D. 80 hours
Correct Answer: C. 32–40 hours
Rationale: Most drugs reach approximately 90–97% steady state after about four to five half-
lives. Five half-lives for this drug would be 40 hours.
4.
Which organ is primarily responsible for hepatic phase I drug metabolism?
A. Kidney
B. Liver
C. Lung
D. Spleen
Correct Answer: B. Liver
Rationale: The liver is the major site of drug metabolism. Phase I reactions commonly involve
oxidation, reduction, or hydrolysis, frequently mediated by CYP450 enzymes.
5.
A patient with severe liver disease is prescribed a highly protein-bound medication. Which
pharmacokinetic change may increase the active drug concentration?
A. Increased albumin synthesis
B. Reduced free drug concentration
,C. Reduced protein binding
D. Increased renal filtration
Correct Answer: C. Reduced protein binding
Rationale: Liver disease can decrease albumin production. Less protein binding can increase the
free, pharmacologically active fraction of highly protein-bound drugs.
6.
A drug produces its therapeutic effect by binding to a receptor and activating it. This drug is best
described as a:
A. Competitive antagonist
B. Partial antagonist
C. Agonist
D. Inverse inhibitor
Correct Answer: C. Agonist
Rationale: An agonist binds to a receptor and activates it, producing a biological response.
7.
What is the primary purpose of a loading dose?
A. Prevent renal excretion
B. Rapidly achieve a therapeutic drug concentration
C. Permanently increase receptor sensitivity
D. Reduce drug absorption
Correct Answer: B. Rapidly achieve a therapeutic drug concentration
Rationale: A loading dose is larger than the maintenance dose and is used when rapid
attainment of therapeutic concentrations is clinically important.
8.
Which patient is most likely to experience increased drug accumulation because of impaired
elimination?
, A. Patient with increased muscle mass
B. Patient with renal impairment
C. Patient with increased gastric motility
D. Patient with mild hypertension
Correct Answer: B. Patient with renal impairment
Rationale: Drugs eliminated primarily through the kidneys may accumulate when renal function
is reduced, increasing the risk of toxicity.
9.
A medication has a narrow therapeutic index. What does this indicate?
A. Large difference between therapeutic and toxic concentrations
B. Small difference between therapeutic and toxic concentrations
C. Drug cannot cause adverse effects
D. Drug is eliminated rapidly
Correct Answer: B. Small difference between therapeutic and toxic concentrations
Rationale: Drugs with a narrow therapeutic index require careful dosing and monitoring
because toxic concentrations are relatively close to therapeutic concentrations.
10.
Which route generally provides the most complete and predictable systemic bioavailability?
A. Oral
B. Subcutaneous
C. Intravenous
D. Rectal
Correct Answer: C. Intravenous
Rationale: IV administration delivers the medication directly into systemic circulation, giving
essentially 100% bioavailability.
11.
Foundations Pre-Assessment Complete Question
Bank 2026-2027: 450 Questions with Detailed
Answers & Rationales Guaranteed Pass Study
Guide
WGU D027 Advanced Pathopharmacological Foundations — Practice Question Bank
Questions with Answers & Rationales
These are original exam-style practice questions, not copied WGU assessment items.
1.
A patient taking an ACE inhibitor develops a persistent dry cough. Which mechanism best
explains this adverse effect?
A. Increased aldosterone secretion
B. Accumulation of bradykinin
C. Increased angiotensin II production
D. Increased sodium retention
Correct Answer: B. Accumulation of bradykinin
Rationale: ACE normally breaks down bradykinin. ACE inhibition causes bradykinin
accumulation, which can produce a persistent dry cough.
2.
Which pharmacokinetic process describes movement of a drug from the bloodstream into body
tissues?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: B. Distribution
,Rationale: Distribution is the movement of a drug from systemic circulation into tissues and
body fluids. Absorption is entry into the bloodstream, metabolism is chemical modification, and
excretion is removal.
3.
A drug has a half-life of 8 hours. Approximately how long would it take to reach near steady-
state concentrations with repeated dosing?
A. 8 hours
B. 16 hours
C. 32–40 hours
D. 80 hours
Correct Answer: C. 32–40 hours
Rationale: Most drugs reach approximately 90–97% steady state after about four to five half-
lives. Five half-lives for this drug would be 40 hours.
4.
Which organ is primarily responsible for hepatic phase I drug metabolism?
A. Kidney
B. Liver
C. Lung
D. Spleen
Correct Answer: B. Liver
Rationale: The liver is the major site of drug metabolism. Phase I reactions commonly involve
oxidation, reduction, or hydrolysis, frequently mediated by CYP450 enzymes.
5.
A patient with severe liver disease is prescribed a highly protein-bound medication. Which
pharmacokinetic change may increase the active drug concentration?
A. Increased albumin synthesis
B. Reduced free drug concentration
,C. Reduced protein binding
D. Increased renal filtration
Correct Answer: C. Reduced protein binding
Rationale: Liver disease can decrease albumin production. Less protein binding can increase the
free, pharmacologically active fraction of highly protein-bound drugs.
6.
A drug produces its therapeutic effect by binding to a receptor and activating it. This drug is best
described as a:
A. Competitive antagonist
B. Partial antagonist
C. Agonist
D. Inverse inhibitor
Correct Answer: C. Agonist
Rationale: An agonist binds to a receptor and activates it, producing a biological response.
7.
What is the primary purpose of a loading dose?
A. Prevent renal excretion
B. Rapidly achieve a therapeutic drug concentration
C. Permanently increase receptor sensitivity
D. Reduce drug absorption
Correct Answer: B. Rapidly achieve a therapeutic drug concentration
Rationale: A loading dose is larger than the maintenance dose and is used when rapid
attainment of therapeutic concentrations is clinically important.
8.
Which patient is most likely to experience increased drug accumulation because of impaired
elimination?
, A. Patient with increased muscle mass
B. Patient with renal impairment
C. Patient with increased gastric motility
D. Patient with mild hypertension
Correct Answer: B. Patient with renal impairment
Rationale: Drugs eliminated primarily through the kidneys may accumulate when renal function
is reduced, increasing the risk of toxicity.
9.
A medication has a narrow therapeutic index. What does this indicate?
A. Large difference between therapeutic and toxic concentrations
B. Small difference between therapeutic and toxic concentrations
C. Drug cannot cause adverse effects
D. Drug is eliminated rapidly
Correct Answer: B. Small difference between therapeutic and toxic concentrations
Rationale: Drugs with a narrow therapeutic index require careful dosing and monitoring
because toxic concentrations are relatively close to therapeutic concentrations.
10.
Which route generally provides the most complete and predictable systemic bioavailability?
A. Oral
B. Subcutaneous
C. Intravenous
D. Rectal
Correct Answer: C. Intravenous
Rationale: IV administration delivers the medication directly into systemic circulation, giving
essentially 100% bioavailability.
11.
